Mitsubishi UFJ Asset Management’s Beam Therapeutics BEAM Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$292K	Sell	8,505 -2,206	-21%	-$66.6K	﹤0.01%	966
2026 Q1	$255K	Sell	10,711 -265	-2%	-$7.35K	﹤0.01%	942
2025 Q4	$298K	Sell	10,976 -2,350	-18%	-$60K	﹤0.01%	951
2025 Q3	$323K	Buy	13,326 +26	+0.2%	+$517	﹤0.01%	935
2025 Q2	$226K	Buy	13,300 +2,808	+27%	+$48.9K	﹤0.01%	965
2025 Q1	$205K	Buy	10,492 +879	+9%	+$23K	﹤0.01%	955
2024 Q4	$244K	Sell	9,613 -995	-9%	-$25.4K	﹤0.01%	962
2024 Q3	$260K	Sell	10,608 -1,002	-9%	-$25.9K	﹤0.01%	931
2024 Q2	$272K	Buy	11,610 +3,970	+52%	+$97.5K	﹤0.01%	927
2024 Q1	$252K	Sell	7,640 -350	-4%	-$10.9K	﹤0.01%	935
2023 Q4	$206K	Buy	7,990 +59	+0.7%	+$1.47K	﹤0.01%	1011
2023 Q3	$191K	Hold	7,931	–	–	﹤0.01%	1026
2023 Q2	$253K	Buy	+7,931	New	+$257K	﹤0.01%	1006

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Mitsubishi UFJ Asset Management's BEAM Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management reduced its Beam Therapeutics (BEAM) stake by 21% in Q2 2026, selling an estimated $66.6K and leaving 8,505 shares worth $292K. The position accounts for ﹤0.01% of the portfolio, ranked #966.

Mitsubishi UFJ Asset Management first reported a position in BEAM in Q2 2023 and has held it in 13 quarters since. The position peaked at $323K in Q3 2025. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

Mitsubishi UFJ Asset Management held 8,505 shares of Beam Therapeutics worth $292K as of Q2 2026.
Mitsubishi UFJ Asset Management sold 2,206 Beam Therapeutics shares in Q2 2026, an estimated $66.6K.
Beam Therapeutics made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #966 holding.
Mitsubishi UFJ Asset Management first reported a position in Beam Therapeutics in Q2 2023 and has held it in 13 quarters since.
Mitsubishi UFJ Asset Management's Beam Therapeutics position peaked at $323K in Q3 2025.
277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.